421 results about "Urinary system" patented technology

Apparatus and methods are provided, including a bladder stimulator that includes an elongate element adapted to pass through a urethra or adapted to pass through another opening in the bladder, an expandable body coupled to said elongate element, and an array of one or more stimulator contacts coupled to the expandable body, the array including at least one contact adapted to contact a portion of a bladder of a subject when the expandable body is inserted in the bladder and expanded. A controller stimulates the portion of the bladder by driving a pulse into the bladder via the contact, the pulse having a frequency of 5 Hz-1 kHz. Other applications are also described.

A urological balloon catheter has electrodes in a region of its shaft proximally adjoining the balloon, which electrodes lie uncovered on the outer surface of the shaft and can be connected to a high-frequency generator via lines which run through the shaft in the proximal direction.

Systems and methods treat urologic dysfunctions by implanting a lead and electrode in a tissue region affecting urologic function, and implanting a pulse generator in an anterior pelvic region remote from the electrode. Bilateral stimulation of the left and/or right branches of the dorsal genital nerves using a single lead implanted in adipose or other tissue in the region at or near the pubic symphysis is able to treat urinary incontinence.

A method for treating urinary incontinence includes the steps of inserting into the woman's vagina a first disposable device, removing the first disposable device, and inserting a second disposable device substantially identical to the first disposable device. The disposable devices have a working portion with opposed faces to provide support to an associated urinary system and, optionally, an anchoring portion to maintain the disposable device in place during use. The working portion also has. The working portion also has an insertion equivalent diameter ranging from about 10 to about 25 mm and a use equivalent diameter ranging from about 25 to about 35 mm under an expansion pressure of about 20 to about 150 cm H₂O.

A method for treating urinary incontinence includes the steps of inserting into the woman's vagina a first disposable device, removing the first disposable device, and inserting a second disposable device substantially identical to the first disposable device. The disposable devices have a generally cylindrical working portion with opposed faces to provide support to an associated urinary system and an anchoring portion to maintain the disposable device in place during use. The working portion also has an initial equivalent diameter ranging from about 20 to about 170 mm, an insertion equivalent diameter ranging from about 5 to about 25 mm, a use equivalent diameter ranging from about 20 to about 40 mm and a length ranging from about 20 to about 60 mm. The anchoring portion also has an initial equivalent diameter ranging from about 20 to about 60 mm, an insertion equivalent diameter ranging from about 10 to about 25 mm, a use equivalent diameter ranging from about 20 to about 60 mm and a length ranging from about 10 to about 50 mm.

Natural and/or synthetic materials to form a strong barrier between the skeletal system and the great vessels. In the preferred embodiments, a natural or synthetic material is used to prevent scar tissue from forming around the vessels and/or to act as barrier placed between the vessels and the skeletal system, including the spine. Devices according to the invention may also be used over the dura and nerves following laminectomy procedures, between the sternum and the pericardium or heart following cardiac procedures, in intra-abdominal procedures such as intestinal or vascular surgery, over the brain in intra-cranial surgery, over the ovaries or other organs or tissues in the female genitourinary system, over the prostate or other organ or tissues in the male genitourinary system, or in other surgeries on humans or animals.

The present invention is directed to methods for treating diarrhea, both chronic or acute forms, by the administration of a therapeutically or prophylactically effective amount of antibodies and fragments thereof having binding specificity for CGRP. In particular the methods prevent or reduce diarrhea in conditions or treatments resulting in elevated CGRP levels, e.g., in the GI tract (colon) that are associated with diarrhea and/or improper electrolyte and fluid excretion from the bowel or urinary system. More specifically, this invention relates to treatments using the anti-CGRP antibodies and fragments described herein, and binding fragments thereof.

The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin.

The present invention provides devices, a system, and a method for removing kidney stones from the urinary system of a patient with reduced pain and expenses. The system includes expandable, elongated balloon sheaths that deliver and retrieve forceps and a urethral sparing prosthetic stent. The stent is reconstrainable with interwoven nylon strands that are strategically positioned amongst the struts to ensure smooth collapse for removal. An atraumatic coating of PTFE or PET lining on the stent extends from the struts through the tip of the penis to assist patients in passing stones while the stent is in place at the bladder neck. The stent can stay in place for several days while permitting urine drainage. The basket-shaped forceps device has multiple curved, rigid arms to dilate the urethra and capture occluded or embedded stones with a built-in camera. The method is for removing stones through a protected urethral canal.

The invention discloses a medicinal composite preparation containing quinolones, a preparation method thereof and an application thereof. The medicinal composite preparation containing quinolones comprises the following components, by mass, 0.5-95% of a quinolone medicine or a salt compound thereof, 1-97% of an organic acid or a salt compound thereof, 1-98.5% of a sweetener, 0-45% of a flavor enhancer, 0-10% of a flavoring agent, and the balance excipient. Finished products prepared from the medicinal composite preparation containing quinolones, which have the characteristics of stability, excellent dispersibility, good palatability and easy absorption, can be used as a broad-spectrum antiseptic, have the advantages of strong bactericidal activity, wide in vivo distribution and no cross drug resistance with other antibiotic medicines, and are effective to bacteria and mycoplasmas, can be used to treat various infectious diseases of the alimentary system, the respiratory system, the urinary system or the skin soft tissue of animals, wherein the diseases are caused by the sensitive bacterial or the mycoplasmas.

The invention provides a preparation method and use of a polygonum capitatum extract. The preparation method comprises the following steps of: extracting polygonum capitatum by using water or an aqueous alcohol system, recovering ethanol and making the extracting solution pass through a macroporous absorption resin; eluting by using water or eluting by using water and low-concentration alcohol, and eluting by using high-concentration alcohol; and collecting eluant, recovering a solvent under reduced pressure, and drying to prepare the polygonum capitatum extract, wherein the content of general flavone is no less than 8 percent and the content of gallic acid is no less than 2 percent. The extract has effects of clearing away heat and reducing fire and promoting diuresis for stranguria, mainly treats pyretic stranguria, and is used for treating urinary system infection and inflammation and other diseases.

A Chinese medicine in the form of pill, dripping pill, tablet or soft capsule for treating the diseases in urinary system is prepared from 8 Chinese-medicinal materials including lysimachia, tuckahoe, plantain bark, imperate rhizome, etc through extracting in water, concentating, adding additives and shaping. Its quality control method is also disclosed.

The invention relates to a nutritional composition for calcium supplement. The nutritional composition includes Ca, P and omega-3 unsaturated fatty acid, the Ca:P ratio is 1.3-2.5:1, the Ca:omega-3 unsaturated fatty acid ratio is 1:0.2-4, a mineral matter calcium source comprises one or a plurality of milk mineral, calcium carbonate, calcium gluconate, calcium amino acid chelate, calcium phosphate, calcium hydrogen phosphate and calcium lactate, and a mineral matter phosphorus sauce comprises one or a plurality of milk mineral, calcium phosphate and calcium hydrogen phosphate. A pharmaceutically or bromatologically acceptable carrier is added to the above raw materials to prepare various oral liquid preparations or solid and semisolid preparations. The nutritional composition having the above combination has the advantages of full performance of the respective efficacies of above three nutrients, synergistic effect of the three nutrients, improvement of the absorption rate of Ca in the body, and increase of the bioavailability of Ca, makes an eater still have a good effect without reverse after the supplementation of the nutritional composition is stopped for a long time, especially overcomes the easy appearing disadvantage of calculi caused by present calcium preparations, and realizes the efficacy of no kidney (or urinary system) calculi during the calcium supplementation.

The invention relates to a Chinese medicament for treating benign prostatic hyperplasiabrain, and belongs to the field of Chinese medicaments for treating urinary system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: plantain seed, Chinese angelica, root of rehmannia, oriental waterplantain rhizome, lucid ganoderma, radix pseudo-ginseng and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, disinhibiting water and dispersing swelling, and excreting dampness and treating stranguria, and has the advantages of obvious effect, exact medicinal effect and quick response.

The invention relates to a medicine for treating the calculus of the urinary system, which is prepared from the following Chinese herbal medicines in parts by weight: 3 parts of radix aristolochiae, 3 parts of serissa foetida comm., 4 parts of pyrrosia lingua, 9 parts of herba lysimachiae, 4 parts of japanese fern spore, 5 parts of plantain seed, 3 parts of talcum powder, 3 parts of glauber's salt, 4 parts of otolithum sciaenae, 6 parts of sparrow-tongue, 4 parts of chicken's gizzard-membrane, 2 parts of licorice, 4 parts of succinum, 4 parts of trogopterus dung, 5 parts of lilac pink, 2 parts of ground beetle, 4 parts of vaxxaria seed, 3 parts of rhizoma zedoariae, 4 parts of twotooth achyranthes root, 4 parts of great burdock fruit, 3 parts of earthworm, 2 parts of scaly anteater, 3 parts of rhizoma alismatis, 3 parts of astragalus root, 3 parts of radix codonopsis pilosulae, 3 parts of turmeric, 2 parts of blister beetle and 4 parts of rhizoma sparganii; the medicine is prepared by pulverizing the Chinese herbal medicines according to the mixture ratio, adding 1-2% of pure gooey, stirring, braising for 100-120 minutes to prepare a pill after cooling. The medicine has the effects of reducing fever, removing dampness by diuresis, strengthening the spleen, supplementing qi, promoting blood circulation, dissolving stasis and the like, is used for treating renal calculus, ureteral calculus, vesical calculus and urethral calculus and can be used for treating oledocholithiasis, hepatolithiasis and cholecystolithiasis.

The invention discloses a medicinal capsule for treating urinary system disease and preparation method, wherein the preparation comprises longspur epimedium 7.5-70%, prepared rehmannia root 6-50%, drynaria 5-65%, astragalus root 5-40%, radix salvia miltiorrhiza 5-60%, edible black fungus 3-20%, and cucumber seeds 5-30%.

The invention relates to a method for preparing a pharmaceutical composition for treating diseases of the urinary system and a method for detecting components thereof. The pharmaceutical composition comprises the components of desmodium styracifolium, corn silk, pyrrosia lingua, herba abri, tuckahoe, herba plantaginis, lygodium japonicum and rhizoma imperatae. The method for preparing the pharmaceutical composition comprises the following steps: step 1: dividing the tuckahoe into two parts; step 2: pulverizing the part of the tuckahoe accounting for 80-90% of total weight into fine powder; step 3: decocting the rest tuckahoe and the other seven crude drugs with water; and step 4: adding the fine tuckahoe powder, evenly mixing, drying, pulverizing into fine powder, screening, adding proper amounts of auxiliary materials, evenly mixing, pelletizing, drying, and sorting up the granules. The detecting method comprises the following steps: taking the pharmaceutical composition as the sample solution, and taking a pyrrosia lingua control medicine as the control medicine solution. The preparation technique and the detecting technique of the invention have the advantages of low cost and simple processing, reduce the heating time of the drugs, and are suitable for wide application in clinical treatment.

The invention discloses an application of niclosamide or pharmaceutically-acceptable salts thereof in preparing anti-tumor drugs, which provides a candidate drug for tumor patients and may further improve the therapeutic effect and the prognosis to patients. The effectiveness of niclosamide or pharmaceutically-acceptable salts thereof on various tumor cells indicates that the composition may be used for treating various cancers such as cerebroma, genitourinary tumor, lymphatic system, stomach cancer, cancer of larynx, nasopharyngeal cancer, skin cancer, bone cancer, leukaemia, leukaemia, breast cancer, histiocytic lymphoma, non-small-cell lung cancer, small-cell lung cancer, lung adenocarcinoma, epidermoid cancer, pancreatic cancer, prostatic cancer, liver cancer and epithelial cell cancer.

The invention discloses a bladder intermittent drainage system which comprises a urine pipe, a controllable conducting switch, a drainage bag liquid inlet pipe and a drainage bag provided with a liquid discharging valve. The controllable conducting switch is arranged between the urine pipe and the drainage bag liquid inlet pipe and used for controlling communication and blocking of an inner cavity of the urine pipe and an inner cavity of the drainage bag liquid inlet pipe. The controllable conducting switch comprises a power supply, a controller, a coil, a conducting slide block and a magnetic piece. The controller controls a power-up state of the coil so as to enable magnetic force produced by the coil and magnetic force of the magnetic piece to interact, and therefore the conducting switch can be turned on or turned off. The bladder intermittent drainage system has the advantages that urine can be automatically drained in time, the phenomenon of infection of the urinary system caused by regurgitation of the urine when the urine is not drained in time is avoided, and workloads of nursing staff are relieved, operation is convenient to perform, and the structure is simple. In addition, the requirement for material performance and physical restorability of the urine pipe or the drainage bag liquid inlet pipe is lowered.

A Chinese medicine in the form of non-sugar particles for treating infection in urinary system, cystitis, nephritis, urethra calculus, hematuria, etc is prepared from 8 Chinese-medicinal materials including lysimachia, tuckahoe, pyrrosia leaf, imperate rhizome, etc. Its preparing process is also disclosed.

The present invention belongs to the field of medicine technology. The Carbazochrome liquid contains Carbazochrome 0.002-0.5 wt%, antioxidant 0-10 wt%, osmotic pressure regulator 0.8-75 wt%, and injection water 20-99.1 wt%. The preparation process of the Carbazochrome liquid includes dissolving osmotic pressure regulator with partial injection water in a compounding tank; adding injection level active carbon through heating and stirring for adsorption for 30 min; filtering and decarbonizing with titanium rod and adding rest injection water to obtain the solution I; dissolving Carbazochrome and antioxidant in solution I, adding injection level active carbon for adsorption for 30 min, filtering and decarbonizing with titanium rod, regulating pH value, fine filtering, detecting, packing in bottle, disinfecting and other steps. The medicine is used in intravenous transfusion for treating various hemorrhage diseases.